Effects of Ca ++  on lipolysis in human omental adipose tissue in vitro.
D000085:Acetates / Q000494:pharmacology; D000262:Adenylyl Cyclases; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D002087:Butyrates / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D003864:Depression, Chemical; D004789:Enzyme Activation; D005990:Glycerol / Q000096:biosynthesis; D006018:Glycols / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008049:Lipase; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008274:Magnesium / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009852:Omentum / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D000085:Acetates; D002087:Butyrates; D006018:Glycols; D013806:Theophylline; D000242:Cyclic AMP; D008049:Lipase; D000262:Adenylyl Cyclases; D008274:Magnesium; D007545:Isoproterenol; D005990:Glycerol; D002118:Calcium; D009638:Norepinephrine